MGTX•benzinga•
MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars
Summary
MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 13, 2025 by benzinga